此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Augmenting rTMS With Cognitive Control Training in Major Depressive Disorder

2021年4月5日 更新者:Stephan F. Taylor、University of Michigan

Augmenting Repetitive Transcranial Magnetic Stimulation (rTMS) With Cognitive Control Training in Major Depressive Disorder (MDD)

Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for MDD, but the overall effect sized of the treatment is equivalent to antidepressant pharmacotherapy, and responses are highly variable. Given that rTMS is usually given to patients who have failed pharmacotherapy, a more effective alternative is needed.

Therefore, this study will combine computerized cognitive training (CCT) during standard rTMS treatments and assess its feasibility, tolerability, and changes in cognitive control performance and depression symptoms.

Participants that agree to the study and meet eligibility will receive standard rTMS (generally 25-36 daily treatments) along with CCT (starting on day 5 of treatment until the pre-taper treatment). In addition, to CCT participants will be asked to complete assessments before and after treatment

研究概览

详细说明

This project will also have a registry for participants that are approached to be in the clinical trial with the CCT but don't wish to be enrolled. Although the registry will be available for these participants, the information entered into this ClinicalTrials.gov registration will reflect the clinical trial portion of this project.

研究类型

介入性

注册 (实际的)

4

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Michigan
      • Ann Arbor、Michigan、美国、48109
        • University of Michigan

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 99年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Diagnosis of major depressive disorder
  • Eligible to receive and recommended for rTMS for depression
  • Willingness to complete computerized cognitive training and undergo brain stimulation procedures
  • Must be enrolled as a Michigan Medicine patient and currently receiving TMS treatment as part of your clinical care.

Exclusion Criteria:

  • History of serious neurological illness or brain injury (e.g., stroke)
  • Poor visual acuity impairing performance on the computerized tasks (eyeglasses must be removed for rTMS treatment, but contacts are permissible)
  • Diagnosed intellectual disability
  • Inability to manipulate a tablet device while seated in the rTMS chair

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:基础科学
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Computerized Cognitive Training (CCT)
The patients will receive CCT during their standard rTMS treatments (after having 5 days of treatment until the pre-taper treatment).
After having four rTMS sessions without CCT, the patients will perform CCT (starting day 5) during the rTMS session, which typically last from 20-40 minutes. A course of rTMS therapy includes from 25-36 treatments, given daily, until the last 5-6 treatments, given as a 'taper' over 2 weeks. CCT will be paired with rTMS up until the taper begins. In addition, they will have assessments prior to and after the therapy.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Feasibility assessed by percentage of CCT sessions completed during rTMS
大体时间:approximately 30 days (usually 20-30 sessions)
Percentage CCT sessions completed: (number of sessions completed/number of sessions assigned) X 100
approximately 30 days (usually 20-30 sessions)

次要结果测量

结果测量
措施说明
大体时间
Time on task during treatment
大体时间:For each day: 45 min; for entire treatment: approx 30 days
Percentage time on task: (Time engaged with task/total time of task assigned)X100, averaged over all active sessions
For each day: 45 min; for entire treatment: approx 30 days
Acceptability of CCT
大体时间:through study completion date, up to 2 years
Percentage: (Number of eligible patients accepting CCT/number of patients approached but not accepting CCT) x 100
through study completion date, up to 2 years
Cognitive Control Performance change over course of treatment
大体时间:Approximately 30 days (usually 20-30 sessions)
Average percentage correct trials on n-back working memory task for first 2 sessions minus average percentage correct trials for last 2 sessions.
Approximately 30 days (usually 20-30 sessions)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2019年8月27日

初级完成 (实际的)

2021年4月1日

研究完成 (实际的)

2021年4月1日

研究注册日期

首次提交

2020年3月19日

首先提交符合 QC 标准的

2020年3月19日

首次发布 (实际的)

2020年3月23日

研究记录更新

最后更新发布 (实际的)

2021年4月8日

上次提交的符合 QC 标准的更新

2021年4月5日

最后验证

2021年4月1日

更多信息

与本研究相关的术语

其他研究编号

  • HUM00161598

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅